Vedolizumab

• ENTYVIO 300 MG INFUZYONLUK COZELTI KONSANTRESI ICIN TOZ (1 FLAKON)kode batang: 8699456790096

Tidak ada catatan makanan tercatat untuk zat aktif ini.

• NatalizumabMAYOR

  Mengonsumsi Vedolizumab bersama Natalizumab dapat meningkatkan risiko atau keparahan leukoensefalopati multifokal progresif ve imunosupresi (penekanan kekebalan).

  Tampilan ahli

  The risk or severity of progressive multifocal leukoencephalopathy and immunosuppression can be increased when Vedolizumab is combined with Natalizumab.

• 2-MethoxyethanolMODERAT

  Mengonsumsi 2-Methoxyethanol bersama Vedolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Vedolizumab.

• AbataceptMODERAT

  Mengonsumsi Abatacept bersama Vedolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abatacept is combined with Vedolizumab.

• AbciximabMODERAT

  Mengonsumsi Abciximab bersama Vedolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abciximab is combined with Vedolizumab.

• AbetimusMODERAT

  Mengonsumsi Abetimus bersama Vedolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abetimus is combined with Vedolizumab.

• AdalimumabMODERAT

  Mengonsumsi Adalimumab bersama Vedolizumab dapat meningkatkan risiko atau keparahan infeksi.

  Tampilan ahli

  The risk or severity of infection can be increased when Adalimumab is combined with Vedolizumab.

• AdecatumumabMODERAT

  Mengonsumsi Adecatumumab bersama Vedolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adecatumumab is combined with Vedolizumab.

• AfelimomabMODERAT

  Mengonsumsi Afelimomab bersama Vedolizumab dapat meningkatkan risiko atau keparahan infeksi.

  Tampilan ahli

  The risk or severity of infection can be increased when Afelimomab is combined with Vedolizumab.

• AldesleukinMODERAT

  Mengonsumsi Aldesleukin bersama Vedolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Aldesleukin is combined with Vedolizumab.

• AldosteroneMODERAT

  Mengonsumsi Aldosterone bersama Vedolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Aldosterone is combined with Vedolizumab.